APA (7th ed.) Citation

H, X., JF, Z., & Q, L. (2021). Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Dove Medical Press.

Chicago Style (17th ed.) Citation

H, Xie, Zhang JF, and Li Q. Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Dove Medical Press, 2021.

MLA (8th ed.) Citation

H, Xie, et al. Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Dove Medical Press, 2021.